Order Article Reprints

Saraiva DP, Azeredo-Lopes S, Antunes A, Salvador R, Borralho P, Assis B, Pereira IL, Seabra Z, Negreiros I, Jacinto A, et al. Expression of HLA-DR in Cytotoxic T Lymphocytes: A Validated Predictive Biomarker and a Potential Therapeutic Strategy in Breast Cancer. Cancers. 2021; 13(15):3841. https://doi.org/10.3390/cancers13153841

Saraiva, Diana P., Sofia Azeredo-Lopes, Ana Antunes, Rute Salvador, Paula Borralho, Beatriz Assis, Isabel L. Pereira, Zita Seabra, Ida Negreiros, António Jacinto, and et al. 2021. "Expression of HLA-DR in Cytotoxic T Lymphocytes: A Validated Predictive Biomarker and a Potential Therapeutic Strategy in Breast Cancer" Cancers 13, no. 15: 3841. https://doi.org/10.3390/cancers13153841

Saraiva, D. P., Azeredo-Lopes, S., Antunes, A., Salvador, R., Borralho, P., Assis, B., Pereira, I. L., Seabra, Z., Negreiros, I., Jacinto, A., Braga, S., & Cabral, M. G. (2021). Expression of HLA-DR in Cytotoxic T Lymphocytes: A Validated Predictive Biomarker and a Potential Therapeutic Strategy in Breast Cancer. Cancers, 13(15), 3841. https://doi.org/10.3390/cancers13153841